Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE5A | O76074 | 20/20 | 0.65 |
| ▸ | PDE6C | P51160 | 2/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.59 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.59 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.59 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.53 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7959348 | 0.88 | PDE5A (0.67) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL7962137 | 0.85 | PDE5A (0.67) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL146830 | 0.84 | PDE5A (0.90) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL29611957 | 0.84 | PDE5A (0.90) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL8804332 | 0.83 | PDE5A (0.64) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL23386941 | 0.82 | PDE5A (0.63) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL30848755 | 0.80 | PDE5A (0.71) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL13990504 | 0.80 | PDE5A (0.69) | PDE5APDE6CPDE3BPDE3A | |
| SCHEMBL8480667 | 0.80 | PDE5A (0.69) | PDE5APDE6CHDAC1HDAC2HDAC6 | |
| SCHEMBL13990515 | 0.79 | PDE5A (0.68) | PDE5APDE6CPDE3BPDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6200980-B1 | ADMINISTERING PHENYL PURINONE COMPOUND FOR TREATING PRECANCEROUS LEISONS | CELL PATHWAYS, INC. | 2001-03-13 | — | — | US | disclosed |
| EP-0526004-B1 | Pyrazolopyrimidinone antianginal agents | PFIZER LTD (GB) | 1997-10-08 | — | — | EP | disclosed |
| US-5426107-A | Treatment of cardiovascular disorders, asthma, allergies | PFIZER INC. (US) | 1995-06-20 | — | — | US | disclosed |
| US-5272147-A | Pyrazolopyrimidinone antianginal agents | PFIZER INC. (US) | 1993-12-21 | — | — | US | disclosed |
| EP-0526004-A1 | Pyrazolopyrimidinone antianginal agents | Pfizer Limited (GB) | 1993-02-03 | — | — | EP | disclosed |